Health authorities in Hong Kong have recalled a batch of a prescription drug used to treat high blood pressure after it was found to contain an impurity that could cause cancer.
The affected product, Irbesartan HCT Actavis Tablets 150/12.5mg, with Hong Kong registration number HK-63378, has been supplied to local private doctors, pharmacies and a private hospital, according to the medicine wholesaler Actavis Hong Kong.
About 3,600 packs, containing 28 tablets each, were said to be on the market...
↧